PRESS RELEASES
November 2026
AELMHU and FEDER are promoting FollowER to improve the transition from pediatric to adult care for rare diseases
The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) and the Spanish Federation of Rare Diseases (FEDER) have launched FollowER, a project aimed at improving the transition from pediatric to adult care for people with rare diseases, by developing a proposed care model that promotes continuity of care and coordination among healthcare professionals.
Read the full press release here.
